Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
439
-
Total 13F shares, excl. options
-
45.7M
-
Shares change
-
+1.13M
-
Total reported value, excl. options
-
$8.76B
-
Value change
-
+$266M
-
Put/Call ratio
-
1.11
-
Number of buys
-
229
-
Number of sells
-
-182
-
Price
-
$191.63
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2020
493 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2020.
REPLIGEN CORP - COMMON STOCK (RGEN) has 439 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.7M shares
of 56.2M outstanding shares and own 81.32% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.53M shares), VANGUARD GROUP INC (4.41M shares), Invesco Ltd. (2.48M shares), MARSHALL WACE, LLP (1.48M shares), FRED ALGER MANAGEMENT, LLC (1.31M shares), Select Equity Group, L.P. (1.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.19M shares), STATE STREET CORP (1.18M shares), 12 West Capital Management LP (1.1M shares), and ALLIANCEBERNSTEIN L.P. (1.09M shares).
This table shows the top 439 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.